Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Neuropathy and presence of emotional distress and depression in longstanding diabetes: Results from the Canadian study of longevity in type 1 diabetes.
Bai JW, Lovblom LE, Cardinez M, Weisman A, Farooqi MA, Halpern EM, Boulet G, Eldelekli D, Lovshin JA, Lytvyn Y, Keenan HA, Brent MH, Paul N, Bril V, Cherney DZI, Perkins BA. Bai JW, et al. Among authors: eldelekli d. J Diabetes Complications. 2017 Aug;31(8):1318-1324. doi: 10.1016/j.jdiacomp.2017.05.002. Epub 2017 May 10. J Diabetes Complications. 2017. PMID: 28599823
Cardiovascular disease guideline adherence and self-reported statin use in longstanding type 1 diabetes: results from the Canadian study of longevity in diabetes cohort.
Bai JW, Boulet G, Halpern EM, Lovblom LE, Eldelekli D, Keenan HA, Brent M, Paul N, Bril V, Cherney DZ, Weisman A, Perkins BA. Bai JW, et al. Among authors: eldelekli d. Cardiovasc Diabetol. 2016 Jan 25;15:14. doi: 10.1186/s12933-015-0318-9. Cardiovasc Diabetol. 2016. PMID: 26809442 Free PMC article.
Commonly Measured Clinical Variables Are Not Associated With Burden of Complications in Long-standing Type 1 Diabetes: Results From the Canadian Study of Longevity in Diabetes.
Weisman A, Rovinski R, Farooqi MA, Lovblom LE, Halpern EM, Boulet G, Eldelekli D, Keenan HA, Brent MH, Paul N, Bril V, Cherney DZ, Perkins BA. Weisman A, et al. Among authors: eldelekli d. Diabetes Care. 2016 May;39(5):e67-8. doi: 10.2337/dc16-0102. Epub 2016 Mar 22. Diabetes Care. 2016. PMID: 27006509 No abstract available.
Prevalence of Insulin Pump Therapy and Its Association with Measures of Glycemic Control: Results from the Canadian Study of Longevity in Type 1 Diabetes.
Boulet G, Halpern EM, Lovblom LE, Weisman A, Bai JW, Eldelekli D, Keenan HA, Brent MH, Paul N, Bril V, Cherney DZ, Perkins BA. Boulet G, et al. Among authors: eldelekli d. Diabetes Technol Ther. 2016 May;18(5):298-307. doi: 10.1089/dia.2015.0216. Epub 2016 Mar 29. Diabetes Technol Ther. 2016. PMID: 27023749
Reducing the need for carbohydrate counting in type 1 diabetes using closed-loop automated insulin delivery (artificial pancreas) and empagliflozin: A randomized, controlled, non-inferiority, crossover pilot trial.
Haidar A, Yale JF, Lovblom LE, Cardinez N, Orszag A, Falappa CM, Gouchie-Provencher N, Tsoukas MA, El Fathi A, Rene J, Eldelekli D, Lanctôt SO, Scarr D, Perkins BA. Haidar A, et al. Among authors: eldelekli d. Diabetes Obes Metab. 2021 Jun;23(6):1272-1281. doi: 10.1111/dom.14335. Epub 2021 Feb 28. Diabetes Obes Metab. 2021. PMID: 33528904 Clinical Trial.
Empagliflozin add-on therapy to closed-loop insulin delivery in type 1 diabetes: a 2 × 2 factorial randomized crossover trial.
Haidar A, Lovblom LE, Cardinez N, Gouchie-Provencher N, Orszag A, Tsoukas MA, Falappa CM, Jafar A, Ghanbari M, Eldelekli D, Rutkowski J, Yale JF, Perkins BA. Haidar A, et al. Among authors: eldelekli d. Nat Med. 2022 Jun;28(6):1269-1276. doi: 10.1038/s41591-022-01805-3. Epub 2022 May 12. Nat Med. 2022. PMID: 35551290 Clinical Trial.